//
Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction
Considerations for Single-Measurement Risk-Stratification Strategies for Myocardial Infarction Using Cardiac Troponin Assays
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association
Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014
Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I